TLX•benzinga•
Wedbush Initiates Coverage On Telix Pharmaceuticals with Outperform Rating, Announces Price Target of $22
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 5, 2025 by benzinga